Skip to main content
letter
. 2019 Nov;104(11):e494–e496. doi: 10.3324/haematol.2019.216374

Figure 1.

Figure 1.

Overall survival in aplastic anemia patients. Overall survival by Kaplan-Meyer method in eltrombopag-treated patients divided according to (A) response to eltrombopag (P=0.005), (B) disease severity (P=0.001), and (C) paroxysmal nocturnal hemoglobinuria (PNH) positivity (P=0.05) at the time of eltrombopag initiation. CR: complete responders; PR: partial responders; NR: non-responders.